Roche Dives Deeper Into Gene Therapy With $1 15 Billion Sarepta Licensing Deal
Manufacturing and industrial operations for the two providers have been combined, but Genentech’s study method has been adopted across the merged firm. Veteran Genentech scientist Richard...